Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2016 | Preclinical investigation of Ibrutinib, a Bruton’s kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypes | Wei, L; Su, YK; Lin, CM; Chao, TY; Huynh, TT; Jan, HJ; Whang-Peng, J; Chiou, JF; Wu, AT; Hsiao, M | Oncotarget 7(43), 69961-975 | |||
2015 | Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma. | Lin, CS; Adebayo, BO; Wu, A; Chen, JH; Peng, YJ; Cheng, MF; Lee, WH; Hsiao, M; Chao, TY; Yeh, CT | Cancer Letters 368(1), 36-45 | |||
2018 | Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition. | Chen, JH; Kuo, KT; Bamodu, OA; Lin, YC; Yang, RB; Yeh, CT; Chao, TY | EXPERIMENTAL CELL RESEARCH 370(2), 444-453 |